Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.75 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 1/20 | 0.75 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Apocynin SCHEMBL109514 | 1.00 | MEN1 (0.75) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL29364797 | 1.00 | MEN1 (0.75) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL30937977 | 0.98 | MEN1 (0.72) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL28029251 | 0.98 | MEN1 (0.72) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL6650865 | 0.98 | MEN1 (0.72) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL109372 | 0.96 | HTT (0.73) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL108512 | 0.96 | HTT (0.73) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL28429584 | 0.96 | HTT (0.73) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL28537029 | 0.94 | HTT (0.71) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL28350129 | 0.93 | MEN1 (0.66) | MEN1KMT2ASLC22A6SLC22A8RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113215095-A | Compositions, media supplements, and stem cell media and methods of culture | 生物岛实验室 | 2021-08-06 | — | — | CN | disclosed |
| WO-2013138523-A1 | METHODS FOR ALTERING LIPIDS IN ALGAE AND YEAST | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-09-19 | — | — | WO | disclosed |
| EP-1381377-B1 | A COMPOSITION INCLUDING A GINKGOLIDE AND APOCYNIN WHICH INTERFERES WITH THE ARACHIDONIC ACID CASCADE | AKL TECHNOLOGIES LTD (GB) | 2012-01-11 | — | — | EP | disclosed |
| WO-2011114220-A1 | NEURO-PROTECTIVE EFFECTS OF ADELOSTEMMA GRACILLIMUM AND ITS ISOLATED COMPOUNDS | BIOTECHNOLOGY RESEARCH CORPORATION LIMITED (CN) | 2011-09-22 | — | — | WO | disclosed |
| US-20110086119-A1 | Preparation for the relief of disease | AKL TECHNOLOGIES LIMITED | 2011-04-14 | — | — | US | disclosed |
| US-20100255211-A1 | ACTINIC ENERGY RADIATION CURABLE INK-JET INK AND INK-JET IMAGE FORMING METHOD | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086119-A1 | Preparation for the relief of disease | F2, PLA2G7, ALOX15B | MEN1 2970/4885KMT2A 4372/4885SLC22A6 4612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.